CMPD OTC
CompuMed, Inc.
1W: -2.6%
1M: -7.4%
3M: +3.1%
YTD: +35.1%
1Y: +59.8%
3Y: +219.5%
5Y: +21.7%
$6.39
-0.04 (-0.62%)
Weekly Expected Move ±6.9%
$6
$6
$6
$7
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$8M
+21.3% ▲
5Y CAGR: +7.5%
Gross Profit
$4M
+18.3% ▲
5Y CAGR: +5.2%
Operating Income
-$17K
-108.1% ▼
Net Income
-$64K
-133.3% ▼
EPS (Diluted)
$-0.05
-132.5% ▼
EBITDA
$808K
-15.2% ▼
5Y CAGR: +5.1%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $6M | $6M | $6M | $6M | $8M |
| YoY Growth | +19.9% | +0.8% | -8.3% | +6.6% | +21.3% |
| Cost of Revenue | $3M | $3M | $3M | $3M | $4M |
| Gross Profit | $3M | $3M | $3M | $3M | $4M |
| Gross Margin | 53.0% | 51.9% | 49.4% | 48.6% | 47.4% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2M | $3M | $3M | $3M | $4M |
| Operating Expenses | $2M | $3M | $3M | $3M | $4M |
| Operating Income | $1M | $550K | -$31K | $205K | -$17K |
| Operating Margin | 16.0% | 8.6% | -0.5% | 3.3% | -0.2% |
| Interest Expense | $58K | $43K | $27K | $38K | $62K |
| Income Before Tax | $1M | $507K | -$15K | $197K | -$43K |
| Tax Expense | $2K | $5K | $18K | $4K | $21K |
| Net Income | $1M | $502K | -$33K | $193K | -$64K |
| Net Margin | 16.9% | 7.9% | -0.6% | 3.1% | -0.9% |
| EPS (Diluted) | $0.69 | $0.30 | $-0.02 | $0.15 | $-0.05 |
| EBITDA | $1M | $1M | $690K | $952K | $808K |
| Shares Outstanding | 2M | 2M | 2M | 1M | 1M |